FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and concerns an agent for myocardial infraction containing an antibody which identifies IL-6 receptor as an active ingredient.
EFFECT: invention provides improved state of an affected zone in myocardial infraction and inhibited left ventricular remodelling following myocardial infraction.
23 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CHRONIC REJECTION INHIBITOR | 2008 |
|
RU2450829C2 |
| AGENTS FOR SUPPRESSING TRANSPLANTED ISLAND DAMAGE FOLLOWING ISLAND TRANSPLANTATION | 2006 |
|
RU2446826C2 |
| THERAPEUTIC AGENT USED FOR GRAFT-VERSUS-HOST DISEASE, CONTAINING INTERLEUKIN-6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT | 2008 |
|
RU2490025C2 |
| THERAPEUTIC AGENT IN SPINAL MARROW INJURY CONTAINING INTERLEUKINE-6 ANTAGONIST | 2004 |
|
RU2358761C2 |
| PROPHYLACTIC DRUG FOR VASCULITIS | 2004 |
|
RU2379054C2 |
| THERAPEUTIC AGENT FOR MESOTHELIOMA | 2004 |
|
RU2392967C2 |
| METHOD OF TREATING INTERLEUKIN-6-DEPENDENT DISEASES | 2004 |
|
RU2509574C2 |
| THERAPEUTIC AGENT FOR TREATING DISEASES RELATED TO JUVENILE CHRONIC ARTHRITIS | 2002 |
|
RU2541165C2 |
| THERAPEUTIC AGENT FOR DISEASES, RELATED TO CHILDREN'S CHRONIC ARTHRITIC DISEASES | 2002 |
|
RU2361613C2 |
| COMPOSITION FOR TREATING DISEASES ASSOCIATED WITH IL-6 | 2016 |
|
RU2730590C2 |
